Addition of gentamicin and rifampin has been challenged due to insufficient evidence of benefit and known increased risk of adverse events. Use of these adjunctive agents requires consultation with Infectious Diseases specialist.

High-dose extended interval aminoglycoside dosing not recommended for synergy. Desired gentamicin trough < 1mg/L. See Aminoglycoside Dosing & Monitoring Guidelines.